MRNA

Moderna, Inc. (NASDAQ: MRNA) reported a net loss for the first quarter of 2024 when the biotechnology company’s revenues declined…

Biotechnology company Moderna, Inc. (NASDAQ: MRNA) reported a sharp decline in revenues and earnings for the fourth quarter of 2023.…

Moderna, Inc. (NASDAQ: MRNA) reported second quarter 2023 earnings results today. Total revenue dropped to $344 million from $4.7 billion…

Moderna, Inc. (NASDAQ: MRNA) reported first quarter 2023 earnings results today. Total revenue was $1.9 billion, compared to $6.1 billion…

Moderna Inc (NASDAQ:MRNA) Q4 2022 Earnings Call dated Feb. 23, 2023. Corporate Participants: Lavina Talukdar — Head of Investor Relations Stephane Bancel — Chief…

Moderna Inc. (NASDAQ: MRNA) reported total revenue of $5.1 billion for the fourth quarter of 2022, down 29% year-over-year due…

Moderna Inc (NASDAQ:MRNA) Q3 2022 Earnings Call dated Nov. 03, 2022. Corporate Participants: Lavina Talukdar — Head of Investor Relations Stephane Bancel — Chief…

Moderna, Inc (NASDAQ: MRNA) Q3 2022 Earnings Conference

Moderna, Inc. (NASDAQ: MRNA) Q1 2022 earnings call dated Aug. 03, 2022 Corporate Participants: Lavina Talukdar — Senior Vice President and Head…

Moderna Inc.  (NASDAQ: MRNA) Q1 2022 earnings call dated May. 04, 2022 Corporate Participants: Lavina Talukdar — Senior Vice President and Head…